Appointment of Chief Operating Officer

RNS Number : 7048T

Instem plc

09 January 2017

 

9 January 2017

Instem plc

("Instem" or the "Company" or the "Group")

Appointment of Chief Operating Officer

Instem (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, announces the appointment of Ms. MaryBeth Thompson as Chief Operating Officer of the Group with immediate effect.  Ms. Thompson, who has not been appointed to the Instem plc main Board, will report to Phil Reason, CEO.

Ms. Thompson has more than 18 years of experience in the life sciences industry, with a primary focus in Regulatory Affairs and Operations with a demonstrable track record as a leader and builder of outsourcing services businesses.

During her tenure at PAREXEL International ("PAREXEL"), a multinational life sciences consulting firm, and its predecessor organisations LIQUENT and CDC Solutions, she established and expanded the regulatory outsourcing services practice from a $1 million revenue business with 30 employees to an international organisation across the US, Europe and India with more than $30 million of revenues and 300 employees.

Prior to PAREXEL, Ms. Thompson worked for AstraZeneca and Wyeth-Ayerst Laboratories in pharmaceutical product development, where she held a range of senior regulatory positions.

Phil Reason, CEO of Instem, commented: "We are delighted to have appointed someone of MaryBeth's calibre and experience to Instem. MaryBeth has a strong track record in building life sciences businesses and we look forward to the benefits she will bring as we embark upon the Company's next phase of growth."

For further information, please contact:

Instem plc	[phone]
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser & Broker)	[phone]
Richard Lindley Nick Owen
Walbrook Financial PR	[phone]
Paul Cornelius	[e-mail]
Helen Cresswell Sam Allen Paul Whittington

About Instem

About Instem plc

Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit www.instem.com

 

END

 

 

NRAUGUAPGUPMGCB